These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 36484927)

  • 1. Long non-coding RNA H19: a potential biomarker and therapeutic target in human malignant tumors.
    Zhang R; Zeng Y; Deng JL
    Clin Exp Med; 2023 Sep; 23(5):1425-1440. PubMed ID: 36484927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. lncRNA H19 regulates epithelial-mesenchymal transition and metastasis of bladder cancer by miR-29b-3p as competing endogenous RNA.
    Lv M; Zhong Z; Huang M; Tian Q; Jiang R; Chen J
    Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1887-1899. PubMed ID: 28779971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
    Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA (lncRNA) H19 in human cancer: From proliferation and metastasis to therapy.
    Hashemi M; Moosavi MS; Abed HM; Dehghani M; Aalipour M; Heydari EA; Behroozaghdam M; Entezari M; Salimimoghadam S; Gunduz ES; Taheriazam A; Mirzaei S; Samarghandian S
    Pharmacol Res; 2022 Oct; 184():106418. PubMed ID: 36038043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA H19 promotes colorectal cancer metastasis via binding to hnRNPA2B1.
    Zhang Y; Huang W; Yuan Y; Li J; Wu J; Yu J; He Y; Wei Z; Zhang C
    J Exp Clin Cancer Res; 2020 Jul; 39(1):141. PubMed ID: 32698890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and role of long non-coding RNA H19 in carcinogenesis.
    Yoshimura H; Matsuda Y; Yamamoto M; Kamiya S; Ishiwata T
    Front Biosci (Landmark Ed); 2018 Jan; 23(4):614-625. PubMed ID: 28930564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H19: An Oncogenic Long Non-coding RNA in Colorectal Cancer.
    Chowdhury PR; Salvamani S; Gunasekaran B; Peng HB; Ulaganathan V
    Yale J Biol Med; 2023 Dec; 96(4):495-509. PubMed ID: 38161577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HHLA2 promotes tumor progression by long non‑coding RNA H19 in human gallbladder cancer.
    Zhang Y; Li H; Lv C; Wu B; Yu Y; Zhong C; Lang Q; Liang Z; Li Y; Shi Y; Zhang J; Xu F; Tian Y
    Int J Oncol; 2022 Sep; 61(3):. PubMed ID: 35920182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA H19 acts as a miR-340-3p sponge to promote epithelial-mesenchymal transition by regulating YWHAZ expression in paclitaxel-resistant breast cancer cells.
    Yan L; Yang S; Yue CX; Wei XY; Peng W; Dong ZY; Xu HN; Chen SL; Wang WR; Chen CJ; Yang QL
    Environ Toxicol; 2020 Sep; 35(9):1015-1028. PubMed ID: 32420678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The double-edged sword of H19 lncRNA: Insights into cancer therapy.
    Shermane Lim YW; Xiang X; Garg M; Le MT; Li-Ann Wong A; Wang L; Goh BC
    Cancer Lett; 2021 Mar; 500():253-262. PubMed ID: 33221454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA H19: A novel oncogene in multiple cancers.
    Yang J; Qi M; Fei X; Wang X; Wang K
    Int J Biol Sci; 2021; 17(12):3188-3208. PubMed ID: 34421359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA H1 promotes cell proliferation and invasion by acting as a ceRNA of miR‑138 and releasing EZH2 in oral squamous cell carcinoma.
    Hong Y; He H; Sui W; Zhang J; Zhang S; Yang D
    Int J Oncol; 2018 Mar; 52(3):901-912. PubMed ID: 29344674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
    Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
    Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non‑coding RNA H19 regulates cell growth and metastasis via the miR‑22‑3p/Snail1 axis in gastric cancer.
    Gan L; Lv L; Liao S
    Int J Oncol; 2019 Jun; 54(6):2157-2168. PubMed ID: 31081061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of the H19/microRNA‑675 axis in the proliferation and epithelial‑mesenchymal transition of human cutaneous squamous cell carcinoma cells.
    Zhang W; Zhou K; Zhang X; Wu C; Deng D; Yao Z
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emerging roles of long non-coding RNA (lncRNA) H19 in gynecologic cancers.
    Ghasemian M; Zehtabi M; Dari MAG; Pour FK; Tabesh GA; Moramezi F; Jafari RM; Barati M; Uddin S; Farzaneh M
    BMC Cancer; 2024 Jan; 24(1):4. PubMed ID: 38166752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An updated review of the H19 lncRNA in human cancer: molecular mechanism and diagnostic and therapeutic importance.
    Alipoor B; Parvar SN; Sabati Z; Ghaedi H; Ghasemi H
    Mol Biol Rep; 2020 Aug; 47(8):6357-6374. PubMed ID: 32743775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of lncRNA H19 promotes nasopharyngeal carcinoma proliferation and metastasis in let-7 dependent manner.
    Zhang Y; Zhu R; Wang J; Cui Z; Wang Y; Zhao Y
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3854-3861. PubMed ID: 31556327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
    Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
    Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lncRNA H19 interacts with miR-140 to modulate glioma growth by targeting iASPP.
    Zhao H; Peng R; Liu Q; Liu D; Du P; Yuan J; Peng G; Liao Y
    Arch Biochem Biophys; 2016 Nov; 610():1-7. PubMed ID: 27693036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.